Prevalence of modifiable risk factors for osteoporosis in patients with rheumatoid arthritis (a clinical study and a review)
Russian Family Doctor · 25.10.2026 · 30 (3) · 15-24
DOI: 10.17816/rfd717376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Russian Family Doctor, online erschienen am 25.10.2026. Verfasst von Daria A. Antonova und 4 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Rheumatoid arthritis (RA) is associated with a high risk of low-energy fractures and osteoporosis, the frequency of which is influenced by both the disease itself and the risk factors for osteoporosis: nonmodifiable (sex, age, family history, etc.) and modifiable. The prevalence of modifiable risk factors for osteoporosis in this patient population is insufficiently studied, which limits the ability to fully prevent osteoporosis. AIM: To comprehensively assess modifiable risk factors for osteoporosis and fractures in patients with RA. METHODS: A cross-sectional study was conducted at a specialized rheumatology hospital. Men and women with a confirmed diagnosis of RA were consecutively included. A questionnaire survey and an analysis of medical records were performed. Risk factors for osteoporosis were assessed using validated questionnaires. In men over 50 years of age and postmenopausal women, the 10-year probability of major osteoporotic fractures was calculated using the FRAX (Fracture Risk Assessment Tool) calculator. RESULTS: The study included 100 patients with RA aged 18 to 88 years, 89% of whom were women; median age 66.5 [54.25; 73] years. The advanced stage (63%), moderate (48%) and high (49%) activity, and seropositivity predominated. 44% of patients had a history of low-energy fractures, osteoporosis was diagnosed in 36%. 40.9% of patients had a FRAX fracture risk above the threshold for therapeutic intervention. Modifiable risk factors were recorded in 98% of patients. The most common were an increased risk of falls (70%), physical inactivity (69%), probable sarcopenia (45%), insufficient calcium intake (40%), and no vitamin D intake (38%). Men and women did not differ in the frequency of modifiable risk factors, except that men were less likely to take vitamin D supplements (27.3% vs 66.3% among women), p = 0.012. The frequency of modifiable risk factors was similar in patients with different stages of RA and did not depend on the duration of the disease, the presence of systemic manifestations, or the use of glucocorticoids. Malnutrition (p = 0.021) and sarcopenia (p = 0.015) were more common in patients with osteoporosis compared with patients without osteoporosis, but the frequency of other modifiable risk factors did not differ between these patient groups. CONCLUSION: Patients with RA have a high prevalence of osteoporosis, fractures, and their modifiable risk factors, most of which are potentially correctable. These findings highlight the need to include assessments of lifestyle, nutrition, physical activity, and fall risk in the standard management of patients with RA, along with monitoring of disease activity.
Zitieren
APA
Antonova, D. A., Orlova, D. D., Hvorova, A. D., Shekoldin, I. S., & Lesnyak, O. M. (2026). Prevalence of modifiable risk factors for osteoporosis in patients with rheumatoid arthritis (a clinical study and a review). Russian Family Doctor, 30(3), 15-24. https://doi.org/10.17816/rfd717376
Vancouver
Antonova DA, Orlova DD, Hvorova AD, Shekoldin IS, Lesnyak OM. Prevalence of modifiable risk factors for osteoporosis in patients with rheumatoid arthritis (a clinical study and a review). Russian Family Doctor. 2026;30(3):15-24. doi:10.17816/rfd717376
BibTeX
@article{Antonova2026,
author = {Antonova, Daria A. and Orlova, Daria D. and Hvorova, Alisa D. and Shekoldin, Ilia S. and Lesnyak, Olga M.},
title = {Prevalence of modifiable risk factors for osteoporosis in patients with rheumatoid arthritis (a clinical study and a review)},
journal = {Russian Family Doctor},
year = {2026},
volume = {30},
number = {3},
pages = {15--24},
doi = {10.17816/rfd717376}
}
EUVIMED